RXRXCAUTIOUS

RXRX Revenue Growth (YoY) Analysis

-61.8%

Updated 155h ago·SEC filings & market data

Key Takeaway

Revenue Growth (YoY) measures how much a company's revenue has increased or decreased compared to the same quarter one year earlier.

Sector Performance

0th percentile

RXRX

-61.8%

Sector Median

9.2%

Sector Avg

14.7%

Prior Period

-57.5%(Aug 2026)

↓ Declining
📊

Deep Analysis

Revenue Growth (YoY) measures how much a company's revenue has increased or decreased compared to the same quarter one year earlier.

At -61.8%, RXRX's revenue has contracted sharply, meaning it brought in far less money than it did a year ago. This sits well below the sector median of 8.9%, placing RXRX at the 0th percentile among its peers, so nearly every comparable company is growing faster or declining less. The trend direction is not available (N/A), and the year-over-year change is also N/A, but the quarter-over-quarter change is -7.5%, showing the decline continues from the prior quarter; historical values of -61.8% (most recent) and -57.5% (prior) indicate the year-over-year drop has deepened. The combination of an extreme negative level and ongoing quarterly contraction points to high investment risk, as revenue erosion shows no near-term stabilization. This directly supports the overall CAUTIOUS verdict, since the company's revenue performance is far worse than its sector and still trending downward.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about RXRX?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are RXRX's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: WHR (-6.8%), FCX (-7.3%), INSP (-7.6%), FOX (-8.6%), NVR (-10.5%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master RXRX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full RXRX research report

Free account — no credit card

RXRX

-61.8%

Sector Median

9.2%

Sector Avg

14.7%

How RXRX's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.